<https://rdf.molmedb.upol.cz/reference/ref3551> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM490984>;
	<http://purl.org/ontology/bibo/doi> "10.1021/acsmedchemlett.0c00505"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM490987>;
	<http://purl.org/ontology/bibo/pmid> "33335676"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM490986>;
	<http://purl.org/dc/terms/bibliographicCitation> "Scott JS, Moss TA, Barlaam B, Davey PRJ, Fairley G, Gangl ET, Greenwood RDR, Hatoum-Mokdad H, Lister AS, Longmire D, Polanski R, Stokes S, Tucker MJ, Varnes JG, Yang B.: Addition of Fluorine and a Late-Stage Functionalization (LSF) of the Oral SERD AZD9833. ACS Med Chem Lett, Volume 11 (12), 2020"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane21>,
		<https://identifiers.org/molmedb/MM490985> .
<https://rdf.molmedb.upol.cz/interaction/int1024852> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3551> .
<https://rdf.molmedb.upol.cz/interaction/int1024853> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3551> .
<https://rdf.molmedb.upol.cz/interaction/int1024850> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3551> .
<https://rdf.molmedb.upol.cz/interaction/int1024851> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3551> .